Literature DB >> 1936232

Accuracy, precision and linearity of the portable flow-volume meter Microspiro HI-298.

E Dompeling1, C P van Schayck, H Folgering, H J van den Hoogen, C van Weel.   

Abstract

The accuracy, precision and linearity of a new portable flow-volume meter, the Microspiro HI-298 (Chest Corporation, Tokyo, Japan), was investigated using a Fleisch no. 4 pneumotachograph as a standard. After connection and calibration of the pneumotachograph and the Microspiro, a healthy subject performed 44 forced vital capacity (FVC) manoeuvres at different levels of lung inflation. The FVC of these expirations ranged from 2.5-5.1 l. Linear regression of Microspiro values (dependent variable) on Fleisch pneumotachograph values (independent variable) showed that a good linear relationship existed: Pearson correlation coefficients ranged from 0.938-0.985. Linearity of the Microspiro was good except for the peak expiratory flow rate (PEFR) and the maximal expiratory flow at 25% of the expired volume (MEF75). The random error (measure of precision) of all flow-volume (F-V) indices was lower than 5%. The systematic error (measure of accuracy) was low for the forced expiratory volume in one second (FEV1) and the FVC (1% and 4.6%, respectively) but much higher for the instantaneous expiratory flows (PEFR 11.0%; MEF75 7.0%; MEF50 8.5%; MEF25 11.4%). Only the total error in FEV1 complied with the tolerance of 4% of the European Community for Coal and Steel (ECCS). When the measured values were adjusted according to the regression equations of this study, all F-V indices were accurate and precise within 5%. It was concluded that the portable Microspiro HI-298 is a useful instrument for bedside, work-site spirometry and for use in general practice.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1936232

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977?

Authors:  P R Tirimanna; C P van Schayck; J J den Otter; C van Weel; C L van Herwaarden; G van den Boom; P M van Grunsven; W J van den Bosch
Journal:  Br J Gen Pract       Date:  1996-05       Impact factor: 5.386

2.  Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?

Authors:  J J den Otter; G M Reijnen; W J van den Bosch; C P van Schayck; J Molema; C van Weel
Journal:  Br J Gen Pract       Date:  1997-08       Impact factor: 5.386

3.  Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.

Authors:  P R Tirimanna; J J Den Otter; C P Van Schayck; C L Van Herwaarden; H Folgering; C Van Weel
Journal:  Br J Gen Pract       Date:  1996-01       Impact factor: 5.386

4.  Respiratory symptoms and pulmonary function among wood dust-exposed joss stick workers.

Authors:  S H Liou; J L Yang; S Y Cheng; F M Lai
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

5.  Asthma in adolescents and young adults: relationship with early childhood respiratory morbidity.

Authors:  B G Kolnaar; A van Lier; W J van den Bosch; H Folgering; C van Herwaarden; H J van den Hoogen; C van Weel
Journal:  Br J Gen Pract       Date:  1994-02       Impact factor: 5.386

6.  Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study.

Authors:  C P van Schayck; E Dompeling; C L van Herwaarden; H Folgering; R P Akkermans; P J van den Broek; C van Weel
Journal:  Br J Gen Pract       Date:  1995-05       Impact factor: 5.386

7.  Asthma and chronic bronchitis. Can family physicians predict rates of progression?

Authors:  C P van Schayck; E Dompeling; R Putters; J Molema; C van Weel
Journal:  Can Fam Physician       Date:  1995-11       Impact factor: 3.275

8.  Diagnosis of asthma and chronic obstructive pulmonary disease in general practice.

Authors:  C P Van Schayck
Journal:  Br J Gen Pract       Date:  1996-03       Impact factor: 5.386

9.  Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.

Authors:  C P van Schayck; E Dompeling; C L van Herwaarden; H Folgering; A L Verbeek; H J van der Hoogen; C van Weel
Journal:  BMJ       Date:  1991-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.